NYSE:PRGO - Perrigo Stock Price, Forecast & News

Perrigo's stock was trading at $46.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PRGO shares have increased by 5.4% and is now trading at $48.52. View which stocks have been mosted impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Perrigo.

Perrigo is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Perrigo.

Perrigo Company PLC (NYSE:PRGO) issued its earnings results on Thursday, February, 27th. The company reported $1.06 EPS for the quarter, missing analysts' consensus estimates of $1.09 by $0.03. The company earned $1.32 billion during the quarter, compared to analysts' expectations of $1.31 billion. Perrigo had a return on equity of 9.56% and a net margin of 3.02%. The firm's revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter last year, the business earned $0.97 EPS. View Perrigo's earnings history.

Perrigo announced a quarterly dividend on Tuesday, February 18th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.225 per share on Tuesday, March 17th. This represents a $0.90 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Thursday, February 27th. This is an increase from Perrigo's previous quarterly dividend of $0.21. View Perrigo's dividend history.

Perrigo updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 27th. The company provided earnings per share (EPS) guidance of 3.95-4.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.37. The company issued revenue guidance of $5.128-5.176 billion, compared to the consensus revenue estimate of $5.02 billion.

7 Wall Street analysts have issued 1 year price targets for Perrigo's stock. Their forecasts range from $52.00 to $70.00. On average, they anticipate Perrigo's share price to reach $57.50 in the next year. This suggests a possible upside of 18.5% from the stock's current price. View analysts' price targets for Perrigo.

News headlines about PRGO stock have trended very positive on Tuesday, InfoTrie reports. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Perrigo earned a news impact score of 3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutPerrigo.

Perrigo saw a increase in short interest in March. As of March 13th, there was short interest totaling 5,269,200 shares, an increase of 11.2% from the February 27th total of 4,740,000 shares. Based on an average daily trading volume, of 1,120,000 shares, the days-to-cover ratio is currently 4.7 days. Currently, 3.9% of the shares of the stock are sold short. View Perrigo's Current Options Chain.

Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), AbbVie (ABBV), Allergan (AGN), Zoetis (ZTS), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira Biosciences (PCRX) and Zogenix (ZGNX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), Allergan (AGN), Celgene (CELG), Netflix (NFLX), AbbVie (ABBV), Amgen (AMGN), Starbucks (SBUX) and Johnson & Johnson (JNJ).

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $48.52.

Perrigo has a market capitalization of $6.61 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,200 workers across the globe. View additional information about Perrigo.

The official website for Perrigo is http://www.perrigo.com/.

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]